COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)

RecruitingOBSERVATIONAL
Enrollment

1,600

Participants

Timeline

Start Date

October 24, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Coronavirus Infectious Disease 2019 (COVID-19)
Interventions
OTHER

Saliva based assay: crude RNA extraction

Crude RNA extraction to inactivate the virus and stabilize the RNA for transport at room temperature. Validation of the crude RNA extraction from saliva in combination with NGS diagnostics and LAMP assays and point of care test (POCT) for rapid detection of viral antigens on patients' samples.

OTHER

Validation of the NGS method

Compare the results obtained with the next-generation sequencing (NGS) method to the nasopharyngeal swabs analysed in a FAMH certified lab.

OTHER

Validation of the LAMP assays

The RNA will be analyzed onsite using the loop mediated amplification (LAMP) assay.

OTHER

Validation of the POCT Antigen and Antibody tests

Rapid point of care tests (POCT) detecting viral protein antigens (Ag) and antibodies (Ab) on patients' samples. POCT are often employed in low income countries, but for COVID-19 they are not yet characterized. Their performance is to be characterized that they can be used as a safe guard if the lab diagnostics fail.

Trial Locations (1)

4410

RECRUITING

Cantonal Office of Public Health, Economics and Health Directorate, Canton Basel-Landschaft, Liestal

All Listed Sponsors
collaborator

ETH Zurich Department for Biosystems, Science and Engineering

UNKNOWN

collaborator

Kanton Basel- Landschaft

UNKNOWN

lead

University Hospital, Basel, Switzerland

OTHER